Coenzyme q10
Conditions
Keywords
ovulation induction, coenzyme q10, pregnancy rate
Brief summary
The study evaluates the effect of coenzyme q 10 on ovulation and subsequent pregnancy in women with polycystic ovarian syndrome. Half of the participants will receive coq10 and ovulation induction with clomiphene and other half would receive a placebo with clomiphene.
Interventions
antioxidant used to decrease oxidative stress and improve fertility prospects
ovulation induction drug
Sponsors
Study design
Eligibility
Inclusion criteria
* Diagnosis of polycystic ovarian syndrome PCOS based on the revised 2003 consensus on diagnostic criteria and long-term health risks related to PCOS (2003). * All women were previously treated with 100 mg of CC daily for 5 days per cycle, for two to three cycles with persistent anovulation or ovulate with very thin endometrium \<5 mm at the time of hCG administration
Exclusion criteria
* Non-consenting. * known autoimmune disorders * prior treatment of endometriosis or surgery to reproductive tract * prior history of pelvic inflammatory disease * those with tubal factors and uterine factors as assessed on history and confirmed by normal hysterosalpingogram. * Thyroid disorder as assessed by history examination and TSH level * Patients with raised FSH
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| number of ovulating women | 1-2 months | transvaginal ultrasound as the disappearance of the leading follicle, presence of follicular fluid in the Douglas pouch and midluteal progesterone \>5 pg/ml. |
| number of pregnancies | 1-2 months | ultrasound visualization of gestational sac with pulsating fetal pole |
Countries
Pakistan